SecBot SecBot
DEFA14A ·Filed Apr 8, 2026

ELAN

Elanco Animal Health Inc
NEUTRAL
Impact 3/10
Horizonimmediate Processed7mo ago SEC0001739104-26-000018
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine annual meeting with no material financial or strategic implications. Traders should note that the company is following standard corporate governance practices, but there are no new financial disclosures or strategic announcements to act upon.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$23.60
T+0 close · Apr 8, 2026 · via day close
Latest settled
+5.95%
T+60 · $25.00
Vs SPY
−4.23%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 8 $23.60entry
  2. T+1 · 7mo ago −0.93%α −1.50% · $23.38
  3. T+5 · 7mo ago −1.65%α −5.17% · $23.21
  4. T+20 · 7mo ago −2.57%α −11.12% · $22.99
  5. T+60 · 4mo ago +5.95%α −4.23% · $25.00
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Elanco Animal Health Inc. (ELAN) is holding its 2026 Annual Meeting of Shareholders, where shareholders will vote on the election of five directors, ratification of the independent auditor, and an advisory vote on executive compensation. This is a routine annual shareholder meeting with no material financial or strategic announcements.

Key Financial Metrics

Vote
director election
Meeting
2026-05-21
Seats Contested
5

Key Facts

  • ELAN is holding its 2026 Annual Meeting of Shareholders
  • Shareholders will vote on the election of five directors
  • Shareholders will vote on ratifying the appointment of Ernst & Young LLP as the independent auditor
  • Shareholders will vote on an advisory vote on executive compensation
  • The meeting is scheduled for May 21, 2026, with voting due by May 20, 2026

Financial Impact

No material financial impact

Risk Factors

  • No immediate financial risks identified
  • No strategic risks identified

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001739104-26-000018
Document: 0001739104-26-000018-index-headers.html0001739104-26-000018
Document: 0001739104-26-000018-index.html0001739104-26-000018
Document: 0001739104-26-000018.txt0001739104-26-000018

Track record

19 reports on ELAN

Performance horizon

5 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +15.03% at T+5 after the May 19, 2026 report. 9 of 10 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $26.68 Now $26.41 −1.01% settles Feb 12
  2. Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $26.78 Now $26.41 −1.38% settles Feb 11
  3. Nov 6, 202610d ago 8-K Bullish 6/10 Entry $25.74 Now $26.41 +2.60% settles Feb 4
  4. Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $23.68 Now $26.41 +11.53% settles Feb 3
  5. Nov 3, 202613d ago 3 Neutral 1/10 Entry $25.31 Now $26.41 +4.35% settles Feb 2
  6. Oct 14, 20264w ago Institutional Cluster Bullish 4/10 Entry $23.54 Now $26.41 +12.19% settles Jan 12
  7. Sep 11, 20269w ago Press Release Neutral 1/10 Entry $23.17 Now $26.41 +13.98% settles Dec 7
  8. Aug 21, 202612w ago Insider Cluster Bullish 6/10 Entry $24.42 Now $26.41 +8.15% settles Nov 17
  9. Aug 21, 202612w ago Insider Cluster Bullish 4/10 Entry $24.42 Now $26.41 +8.15% settles Nov 17
  10. Aug 18, 202612w ago Insider Cluster Bullish 4/10 Entry $24.50 to $26.50 Now $26.41 +7.80% ▲ +8.16% +9.72% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens in 5h 31m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 8, 2026